Insmed Incorporated
INSM
$132.17
$3.853.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.90% | 22.94% | 24.79% | 18.15% | 16.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.90% | 22.94% | 24.79% | 18.15% | 16.98% |
| Cost of Revenue | 33.92% | 21.89% | 41.79% | 26.72% | 26.33% |
| Gross Profit | 14.36% | 23.26% | 19.99% | 15.86% | 14.42% |
| SG&A Expenses | 45.22% | 58.48% | 59.18% | 31.23% | 26.22% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.12% | 38.54% | 41.98% | 34.18% | -7.92% |
| Operating Income | -37.08% | -46.02% | -50.83% | -43.32% | 16.59% |
| Income Before Tax | -6.90% | -63.37% | -26.60% | -38.59% | -22.72% |
| Income Tax Expenses | 48.33% | 54.84% | 26.85% | 86.40% | 58.11% |
| Earnings from Continuing Operations | -7.01% | -63.33% | -26.60% | -38.75% | -22.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.01% | -63.33% | -26.60% | -38.75% | -22.79% |
| EBIT | -37.08% | -46.02% | -50.83% | -43.32% | 16.59% |
| EBITDA | -36.94% | -46.52% | -51.53% | -44.05% | 16.80% |
| EPS Basic | 12.55% | -34.07% | -2.40% | -14.13% | -9.18% |
| Normalized Basic EPS | -8.98% | -15.70% | -18.96% | -12.78% | 24.46% |
| EPS Diluted | 12.51% | -33.96% | -2.40% | -14.19% | -9.16% |
| Normalized Diluted EPS | -8.98% | -15.70% | -18.96% | -12.78% | 24.46% |
| Average Basic Shares Outstanding | 22.37% | 21.83% | 23.63% | 21.57% | 12.47% |
| Average Diluted Shares Outstanding | 22.37% | 21.83% | 23.63% | 21.57% | 12.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |